Desjardins’ financial support will allow Optel Group, a global provider of traceability systems, to extend its traceability service, and diversify its activities not only in the healthcare, medical device and research and development fields, but also in other fields such as food and natural resources.
This assistance also aims at improving Optel’s predominance and influence in one of its usual markets—pharmaceuticals. Optel owns 25% of the global market share for the healthcare track and trace hardware systems market and exhibits its proficiency in securing the medical products’ supply chain.
“Optel is always looking to push limits and rise to next-level, more difficult challenges. These issues that humanity is facing require innovative solutions. This support from Desjardins will allow us to go even further in our growth, by entering new, crucial markets to create a more sustainable world,” says Optel President Louis Roy.
“Desjardins is pleased to grant these loans, because we trust the Optel brand completely. The financial situation of the company is excellent and it was very important to us to support their expansion and growth,” adds Robert Bastien, VP, Business Services at Desjardins Group.
Optel is committed to attaining new objectives, on a larger scale, and Desjardins Group is a critical ally to make those objectives a reality. Desjardins is the leading cooperative financial group in Canada, and stands out with its commitment, financial strength and contribution to sustainable prosperity. The company’s values are aligned, making their collaboration logical, helping Optel maintain its present momentum, and continuing to develop solutions adapted to customer needs and solving real issues.
